Table 1. Comparison of demographics, clinical, and laboratory findings between COVID-19 patients with and without muscle loss.
| Patients with muscle loss | Patients without muscle loss | P | |
|---|---|---|---|
| Gendera (female/male) | 16/27 | 30/77 | 0.328 |
| Age (years)b (mean±SD) | 73.4±10 | 56.4±14 | <0.001 |
| Fevera (yes/no) | 39/4 | 98/9 | 0.542 |
| Respiratory symptomsa (yes/no) | 34/9 | 80/27 | 0.675 |
| Gastrointestinal symptomsra (yes/no) | 12/31 | 16/91 | 0.103 |
| Other symtpomsa (yes/no) | 6/37 | 19/88 | 0.637 |
| Barthel Index (mean±SD) | 54.4±33 | 85.1±26 | <0.001 |
| Hemoglobin (g/l)b (mean±SD) | 11.5±2 | 13.2±2 | <0.001 |
| Red blood cells count (×1012·L−1)b (mean±SD) | 3.9±1 | 4.6±1 | <0.001 |
| White blood cells count (×109·L−1)b (mean±SD) | 9.4±7 | 7.2±4 | 0.019 |
| C-reactive protein (mg/L−1)b (mean±SD) | 71.5±71 | 44±48 | 0.009 |
| Aspartate aminotransferase (U/L)b (mean±SD) | 62.1±139 | 40.7±39 | 0.154 |
| Alanine aminotransferase (U/L)b (mean±SD) | 58.25±130 | 51.9±114 | 0.773 |
| Alkaline phosphatase (U/L)b (mean±SD) | 79.7±37.8 | 69.3±38 | 0.195 |
| Lactate dehydrogenase (U/L)b (mean±SD) | 335±163 | 265.8±116 | 0.008 |
| Creatine phosphokinase (U/L)b (mean±SD) | 147±156 | 124.8±144 | 0.457 |
aFisher’s exact test
bStudent’s t-test; applied level of significance p<0.05.